New ERA-Net “ERA PerMed” on Personalised Medicine
ERA PerMed (2017-2022) is a new ERA-Net Cofund Action on Personalised Medicine (PM), supported by 31 partners of 22 countries and cofunded by the European Commission. It aims to align national and regional research strategies and funding activities, promoting excellence, reinforcing the competitiveness of European players in PM, and enhance the collaboration with non-EU countries.
ERA PerMed partners have decided to conduct together up to 4 Joint Transnational Calls (JTC) and to launch the first and cofunded JTC in order to fund international high quality research projects in PM.
ERA PerMed is thereby closely linked to ICPerMed and will foster the implementation of the ICPerMed Action Plan by funding transnational research projects in the field of PM.